Answer
Tasigna (nilotinib) should not be used during pregnancy unless the woman's clinical condition requires it, because human pregnancy data are absent or limited and animal studies showed reproductive toxicity; if used, the patient must be informed of the potential risk to the foetus.
Sources for this answer
- Tasigna 50mg, 150mg and 200 mg hard capsulesNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 39Document updated
Sources checked